That's what she saidBut big gulps are all I drink.
Ok, Folger.But big gulps are all I drink.
I sold my Facebook stock today...their own research shows they cause up to 5% of hate and 6% of suicide in teenage girls? Yuck. That's not good for business, or my portfolio. Been a long time shareholder, but I'm out.
![]()
Whistleblower: Facebook is misleading the public on progress against hate speech, violence, misinformation
Frances Haugen says in her time with Facebook she saw, "conflicts of interest between what was good for the public and what was good for Facebook." Scott Pelley reports.www.cbsnews.com
Suicide ideation, but you know what the media is running with.WowSanrith Descartes supporting confirmed killers.
Oil can't stay this high. Shale producers are salivating right now. They are going to pump like fiends with oil over $70.Goldman Sachs says airline stocks will plummet if gas stays this high. So be wary. I may not be playing JETS as much as I have.
Don't do that. I had 60k in BTNX at 50 and a year later it went to 400. At the time, no one was saying it would go much higher. So yeah, would have had 500k if I'd sat on it for a year.
You'll go crazy thinking about trades you didn't make, or ended early. Literally, they'll be taking sizes for your straight jacket.
When you motherfuckers get a time machine, I need to borrow it just a few minutes.
If you are following vaccine stocks, I would own BioNTech (BNTX) since they developed the vaccines and licensed to Pfizer. Obviously Pfizer can benefit from all this but I think BNTX is the one that can really explode.
I'd also expect MRNA to report their complete phase 1 data soon (possibly coupled with announcement of their phase 3 initiation), and NVAX will also likely have a Ph1 announcement this month.
I expect all of them to report good binding and neutralization seroconversion rates, so it could be a wild ride up and down, especially as the media realizes these titers don't tell the whole story.
Sad thing is, I knew a nurse in a hospital that told me that Pfizer and BNTX were doing well. It was super volatile then, and I cut my position. In general, I don't touch experimental drugs any more...too binary.Back when BNTX and MRNA were both around $50-70.